Antibiotics are essential for treating bacterial and fungal infections in plants, animals, and humans. Their widespread use in agriculture and the food industry has significantly enhanced animal health and productivity. However, extensive and often inappropriate antibiotic use has driven the emergence and spread of antimicrobial resistance (AMR), a global health crisis marked by the reduced efficacy of antimicrobial treatments. Recognized by the World Health Organization (WHO) as one of the top ten global public health threats, AMR arises when certain bacteria harbor antimicrobial resistance genes (ARGs) that confer resistance that can be horizontally transferred to other bacteria, accelerating resistance spread in the environment. AMR poses a significant global health challenge, affecting humans, animals, and the environment alike. A One-Health perspective highlights the interconnected nature of these domains, emphasizing that resistant microorganisms spread across healthcare, agriculture, and the environment. Recent scientific advances such as metagenomic sequencing for resistance surveillance, innovative wastewater treatment technologies (e.g., ozonation, UV, membrane filtration), and the development of vaccines and probiotics as alternatives to antibiotics in livestock are helping to mitigate resistance. At the policy level, global initiatives including the WHO Global Action Plan on AMR, coordinated efforts by (Food and Agriculture Organization) FAO and World Organisation for Animal Health (WOAH), and recommendations from the O’Neill Report underscore the urgent need for international collaboration and sustainable interventions. By integrating these scientific and policy responses within the One-Health framework, stakeholders can improve antibiotic stewardship, reduce environmental contamination, and safeguard effective treatments for the future.

The effect of dietary ginger powder on the production performance, digestibility, hematological parameters, antioxidant status, dietary oxidation stability, and plasma cholesterol content of broiler chickens was investigated. Ginger powder was included in the diet at 0, 5, 10, or 15 g/kg. Total antioxidant capacity and malondialdehyde in sera samples, superoxide dismutase activity, glutathione peroxidase, catalase, and malondialdehyde in liver samples, and the peroxide value and acid value of the stored diets were evaluated. The results showed that ginger inclusion significantly improved antioxidation indices in broiler sera and liver. Total body weight gain in ginger-supplemented birds was higher than that of control birds (p < 0.048). Supplementing the broiler chickens with ginger powder reduced total feed consumption (p < 0.031). White blood cell counts and the percentage of heterophils in the blood were increased in birds that received ginger supplementation (p < 0.001). The inclusion of ginger in the diet improved dry matter digestibility, crude protein utilization, crude fiber utilization, and ether extract utilization. In addition, blood cholesterol, triglyceride, and very low-density lipoprotein levels were decreased (p < 0.001), and high-density lipoprotein and levels were increased, following the inclusion of ginger in the diet (p < 0.001).

This study evaluated the effectiveness of a new probiotic product developed to reduce the effect of Salmonella infections and compared it to the efficacy of commercial probiotics in broiler chicken. Based on the in vitro assessment of the growth characteristics and safety to human health, four bacterial isolates were isolated, characterized, and identified as excellent candidates for the development of commercial probiotic feed additives for poultry. Compatibility and interactions among the four selected strains were investigated. After that, a preliminary study was conducted in which the selected isolates were evaluated individually in vivo with three different methods of application (water, feed, and oral gavage). The cycle included N = 312 chicks, which were divided into 13 groups, including control, distributed into four batteries, with 78 broiler chickens in each battery. There were eight replicates with 24 chicks in each replicate, and the analysis was randomly done in triplicate. The intentional parameters were growth performance, microbial analysis and humoral immune response. The results of the preliminary study assisted in formulating the new probiotic product. Then In vivo evaluations for the newly formulated product were performed with the comparison with two imported commercial products (Alterion and Galli pro fit) used in poultry farms in Kuwait. The second cycle included N = 96 chicks that were divided into four groups, including control. Each group has three replicates and each replicate has eight chicks, and the analysis was randomly done in triplicate. The results showed that although antibiotics were not used, all the growth parameters were similar and sometimes better than the control. The new product inhibited the growth of salmonella as a control and all chickens in different treatment gained a high mass of meat. The statistical analysis showed that no differences were observed in bird weight, weight gain, feed consumption, and feed efficiency between bacterial strains p>0.05. Also, the different probiotic treatments did not affect the total antibody IgM titers significantly in the broilers (P > 0.05). Thus, the newly formulated product was effective in reducing the salmonella.

There is growing interest in adding marine algae to poultry feed rations. The aim of the present study is to examine the effect of various inclusions of Sargassum sp., Gracilaria sp., and Spirulina sp. on productive performance, serum proteins, liver proteins, meat quality, and antioxidant activity in broiler chickens. There were seven dietary treatments (TRTs) as follows: TRT 1 was the control group without algae; TRT 2 was enriched with Sargassum sp. at 1% of the diet; TRT 3 with Sargassum sp. at 2% of the diet; TRT 4 with Gracilaria sp. at 0.5% of the diet; TRT 5 with Gracilaria sp. at 1% of the diet; TRT 6 with Spirulina sp. at 5% of the diet; TRT 7 with Spirulina sp. at 7.5% of the diet. Each treatment was replicated ten times, with 17 birds per replicate, and the analyses were performed in triplicates. Results of the feed rations proximate analyses revealed that the formulated diets contained the required amounts of protein, fat, fiber, ash, and moisture, to be fed to the broiler chickens. There was no effect of marine algae on the production performance parameters of the birds. All the enriched birds performed normally as the control group. It was shown that enriching the broiler diet with 1% Sargassum sp. Induced an increase in the total serum proteins, while Gracilaria sp. algal inclusion reduced the total serum proteins, compared to the control group. At five weeks of age, enriching broiler diets with 5% Spirulina sp. resulted in a higher concentration of total serum protein-C than the control group and the group enriched with 7.5% inclusion. Enriching the diet of 3- wks old broilers with Sargassum sp. at 2% elevated the proportions of serum LFABP. The maximum proportion of omega 6 fatty acid (∑n-6) was observed in the group of birds that received the control diet, while the proportion of omega 3 fatty acid (∑n-3) was highest in the algae-enriched groups. The results showed that all algal inclusions lowered the ratio of omega-6 to omega-3 fatty acids (∑n-6:∑n-3). Enriching broiler chickens with Spirulina at 5% and 7.5% increased the HDL concentration, compared to the control group. The palatability of meat for color, texture, flavor, appearance, smell, and overall acceptability was not negatively affected by algal inclusions. All algal inclusions enhanced the anti-oxidative status of broilers and lipid oxidative stability of the stored feed rations. In general, it can be concluded that marine algal inclusions showed no effect on the productive performance of the broiler chickens and can be used without any detrimental effects in poultry feed rations.

The global poultry industry faces a major transition driven by bans on antibiotic growth promoters (AGPs) and rising antimicrobial resistance threats. This has intensified the search for effective, sustainable alternatives to maintain productivity, animal health, and food safety. This review provides a comprehensive overview of next-generation probiotics (NGPs) and their evolving role in poultry production, highlighting their mechanisms of action, technological advancements, and applications for improving performance and health. Recent studies were systematically reviewed, covering conventional and NGPs, multi-omics-driven strain identification strategies, engineered microbial systems, and advanced delivery technologies. Key functional aspects, including gut microbiota modulation, immune responses, pathogen control, and productivity metrics were thoroughly assessed. NGPs exhibit enhanced capabilities over traditional probiotics, including improved gut colonization, targeted antimicrobial activity, and precise host immune modulation. Advances in synthetic biology, microencapsulation, and synbiotic formulations enhance their efficacy and stability. Additionally, NGPs also demonstrate significant potential in improving growth performance, feed conversion ratios, intestinal integrity, and enteric pathogen resistance. However, challenges such as strain-specific variability, regulatory constraints, and limited field-level validation persist. NGPs offer a promising and sustainable strategy for modern poultry production. Future integration with precision microbiome engineering, artificial intelligence, and sustainable farming will be essential to realize their full potential and ensure widespread adoption.

Citrullus colocynthis (L.) Schrad., a drought-tolerant member of the Cucurbitaceae family, has been used in traditional medicine for centuries and has recently attracted increasing interest because of its potential pharmacological, agricultural, and ecological applications. This review examines current information on the plant’s distribution, ethnomedicinal uses, phytochemical composition, biological activities, applications in poultry, and ecological significance. Its bioactive constituents include cucurbitacins, flavonoids, phenolic compounds, alkaloids, glycosides, fatty acids, and tocopherols. These compounds have been associated with anticancer, antidiabetic, antimicrobial, antioxidant, anti-inflammatory, neuroprotective, hepatoprotective, and other biological activities, although most of the available evidence comes from in-vitro and preclinical studies. Initial findings also indicate that the plant may have value as a phytogenic feed additive in poultry and as a drought-tolerant species for soil stabilization, rangeland rehabilitation, and desertification control. However, the practical application of these findings is still constrained by differences in research methods, variation in phytochemical composition, limited clinical evidence, and the plant’s narrow therapeutic window and dose-dependent toxicity. Consequently, its therapeutic effectiveness and suitability for routine agricultural use cannot yet be established with certainty. Future research should focus on phytochemical standardization, quality control, thorough toxicological assessment, mechanistic studies, and well-designed clinical and animal trials using standardized preparations. Collectively, the available evidence indicates that C. colocynthis is a promising source of bioactive compounds with potential pharmaceutical, veterinary, and ecological applications, although rigorous scientific validation is required before its safe and effective utilization can be recommended.